Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Horizonte Minerals Plc: Results of Placing
-
TransGlobe Energy Corporation Announces an Update to Its Significant Shareholders
-
MRF 2021 Resource Limited Partnership Second Closing March 24, 2021
-
Form 8.3 - [Scapa Group plc] - (CGWL)
-
Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
Partenaires Ninepoint annonce la première clôture de Ninepoint 2021 Flow-Through Limited Partnership
-
Gold Standard Ventures Announces Full Exercise of Over-Allotment Option and Closing of C$34.5 Million Bought Deal Financing
-
Form 8.3 - [Scapa Group plc] - (CGWL)
-
SailPoint Technologies Holdings (SAIL) PT Raised to $70 at Canaccord Genuity Ahead of Earnings
-
Canaccord Genuity Sees GenMark Diagnostics (GNMK) Trading Above Buyout Comps, PT Raised to $24
-
Calyxt Inc. (CLXT) PT Raised to $16 at Canaccord Genuity
-
UPDATE: Canaccord Genuity Downgrades BlackBerry Ltd. (BB:CN) (BB) to Sell
-
XS Financial Announces Upsizing of Its Previously Announced Private Placement LED by Gravitas Securities and Canaccord Genuity to $7 Million Due to Strong Investor Demand
-
Adicet Bio, Inc. Announces Closing of $152 Million Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
Adicet Bio, Inc. Announces Closing of $152 Million Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
UPDATE: Canaccord Genuity Starts CrowdStrike Holdings (CRWD) at Buy
-
Viant Technology Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Revive Therapeutics Announces Closing of $23.0 Million Short Form Prospectus Offering
-
Mydecine Innovations Group Announces Closing of $17,250,000 Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option
-
Bitcoin Well and Red River Capital Corp. Announce Concurrent Brokered Private Placement of up to $7 Million With Canaccord Genuity Corp. as Agent
-
Travere Therapeutics (TVTX) Prices 6.55M Share Common Offering at $26.75/Sh
-
Form 8.3 - [Scapa Group plc] - (CGWL)
-
Atalaya Mining PLC Announces Issue of Equity
-
Travere Therapeutics Announces Pricing of Public Offering of Common Stock
-
Travere Therapeutics Announces Pricing of Public Offering of Common Stock
-
International Clean Power Dividend Fund Files Final Prospectus
-
Canaccord Genuity Downgrades Mogo Inc. (MOGO:CN) (MOGO) to Hold
-
CMP 2021 Resource Limited Partnership Raises $17,758,000 on First Closing
-
Kaleido Biosciences Announces the Exercise of the Underwriters’ Option to Purchase Additional Shares of Common Stock
-
Kaleido Biosciences Announces the Exercise of the Underwriters’ Option to Purchase Additional Shares of Common Stock
-
Bioventus (BVS) IPO Opens 16% Higher
-
WeedMD Inc. Announces Increase in Bought Deal Equity Financing to $17.5 Million
-
2 Marijuana Stocks Reddit Should Be Talking About
-
Synacor (SYNC) to be Acquired by Centre Lane Partners for $92 Million
-
Synacor Agrees to be Acquired by Centre Lane Partners
-
Columbia Care Inc. (CCHWF) Announces C$25 Million Bought Private Placement Offering
-
Bioventus Announces Pricing of Initial Public Offering
-
Bioventus Announces Pricing of Initial Public Offering
-
WeedMD Inc. Announces $15 Million Bought Deal Equity Financing
-
Rhythm Pharmaceuticals, Inc. Announces Closing of $172.5 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Rhythm Pharmaceuticals, Inc. Announces Closing of $172.5 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
1933 Industries Announces C$3.5 Million Bought Deal Private Placement of Units
-
InMode Ltd. (INMD) PT Raised to $80 at Canaccord Genuity, Following Earnings
-
Viant Technology (DSP) IPO Opens 76% Higher
-
ExOne (XONE) Prices 1.67M Share Offering of Common Stock at $54/sh
-
ExOne Announces Pricing of Public Offering of Common Stock
-
ACETO Corp (ACET) Prices 9.23M Share Common Offering at $13/Sh; Announces Concurrent Private Placement
-
Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement
-
Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement

